RCT: Abrocitinib vs. Placebo or Dupilumab for Atopic Dermatitis
26 Mar, 2021 | 08:27h | UTCAbrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine